Eyedrop recall underscores need for quality focus
An FDA eye drop recall involving sterility concerns highlights the critical role of cGMP compliance, aseptic processing, and Blow-Fill-Seal technology in safe ophthalmic drug manufacturing.
READ MORE
IN THE NEWS
